相关实验视频

Updated: Jul 27, 2025

Mapping the Binding Site of an Aptamer on ATP Using MicroScale Thermophoresis

Mapping the Binding Site of an Aptamer on ATP Using MicroScale Thermophoresis

Published on: January 7, 2017

改善阿帕特默性能:关键因素和策略

Hong Yu^1,2,3,4, Jiangxiong Zhu^1,2,3,4, Guoqing Shen^1,2,3,4

¹School of Agriculture and Biology, Key Laboratory of Urban Agriculture, Ministry of Agriculture, Bor S. Luh Food Safety Research Center, Shanghai Jiao Tong University, Shanghai, 200240, People's Republic of China.

Mikrochimica acta

|June 10, 2023

概括

通过SELEX选择的aptamers显示出希望,但需要优化. 像切断和修改这样的后SELEX策略提高了aptamer性能,用于生物传感和治疗领域的更广泛应用.

科学领域:

生物技术是生物技术.
分子生物学分子生物学
生物化学生物化学

背景情况:

体是通过指数式丰富 (SELEX) 的联体的系统演化选择的单链寡核酸.
它们比抗体具有优势,包括高特异性,低变异性和易于合成.
当前的aptamer性能往往需要改进,以实现实际应用.

研究的目的:

审查影响阿普他默表现的关键因素.
总结和讨论后SELEX优化策略.
强调选择适当的优化方法的重要性.

主要方法:

讨论影响阿帕特默性质的因素.
简要介绍后SELEX优化技术:截断,扩展,突变,修改,分割和多价值集成.
分析每个优化方法背后的机制.

主要成果:

确定了影响阿普他默性能的关键因素.
详细介绍了各种后SELEX优化策略.
通过这些方法,通过这些方法成功地改善了aptamer性能.
提供了对优化机制的见解.

结论:

后SELEX优化对于提高aptamer效用至关重要.
现有多种方法可以提高阿普坦酶的亲和力,特异性和稳定性.
选择正确的优化策略对于最大限度地发挥aptamer在各种应用中的潜力至关重要.

关键词:

亚普特美尔 (Aptamer) 是一种药物.延伸延伸延伸延伸多价值集成多价值集成突变发生和改造在SELEX后的优化.分裂,就是分裂.截断截断是指切断.

更多相关视频

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay

Published on: February 28, 2015

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

相关概念视频

Factors Affecting Protein-Drug Binding: Drug-Related Factors

Factors Affecting Protein-Drug Binding: Drug-Related Factors

Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...